EQUITIES Magazine caught up with Carl Pelzel, President, Chief Executive Officer and Director of Depomed at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference, running March 15-17, 2010 at the Ritz Carlton in Dana Point, California. Click here to listen to the interview, and click here to see a list of companies we have talked to at the conference so far.
Depomed, Inc. (Nasdaq: DEPO) is a specialty pharmaceutical company focused on enhancing pharmaceutical products. Since its founding in August 1995, the company has advanced two products to market and has developed a pipeline with late-stage product opportunities intended to address common medical conditions affecting large patient populations.
About EQUITIES:
Since 1951, EQUITIES Magazine has been a leading media company providing business editorial content designed to serve the needs of business leaders, professionals, institutional investors and retail investors. We are focused on business and the business of making money, not on lifestyle subjects. We publish original reporting in print and on our website, as well as select content at www.nasdaq.com. For 28 years we have hosted our own branded investor conferences that connect public company CEO’s with our loyal readers in the investment community.
Sign up for a FREE one-year subscription
